AtaGenix Custom Phospho-specific Antibody Service Facilitates the Discovery of a Novel Mechanism of G Protein-Mediated Growth Regulation in Tomato

Research Background

Plant vigor directly determines crop yield and photosynthetic efficiency, representing a core focus of global food security research. The G protein signaling pathway is a key regulator of plant growth, but its molecular mechanisms remain incompletely understood. A study published in Cell Reports from Zhejiang University revealed that the G protein γ subunit GGC1, which underwent positive selection during tomato domestication, acts as a negative regulator of plant growth and photosynthesis by suppressing CPK28-mediated phosphorylation of aquaporin PIP1;2 at Thr172. This identified a previously uncharacterized signaling cascade — the GGC1–CPK28–PIP1;2 axis — with direct implications for high-yield crop breeding.

Client Needs

To verify the regulatory mechanism by which GGC1 influences CPK28-mediated PIP1;2 phosphorylation, the research team required an antibody that could: (1) specifically recognize PIP1;2 phosphorylated at Thr172 without cross-reacting with the unmodified form; (2) distinguish Thr172 phosphorylation from neighboring Tyr171 phosphorylation; (3) work in tomato (Solanum lycopersicum) tissue samples via Western Blot for quantitative detection; and (4) detect low-abundance phosphorylated protein with high sensitivity.

Technical Challenges

This project presented unique challenges beyond standard phospho-antibody development:

• Adjacent-site discrimination: Thr172 and Tyr171 are neighboring residues — the antibody had to recognize phospho-Thr172 specifically without cross-reacting with phospho-Tyr171, requiring extremely precise epitope design.
• Plant species specificity: The antibody needed to recognize tomato PIP1;2 sequence, which differs from mammalian aquaporins — standard commercial phospho-antibodies were not available for this target.
• Low abundance detection: Phosphorylated proteins are present at low levels in plant tissues, demanding high affinity and sensitivity to generate quantifiable WB signals from mutant vs. wild-type comparisons.

Customized Solutions

AtaGenix designed a targeted phospho-antibody workflow:

• Sequence Analysis & Epitope Design: AtaGenix analyzed the PIP1;2 sequence surrounding Thr172 and evaluated conservation across tomato aquaporin family members. A synthetic phosphopeptide containing pThr172 was precisely designed with optimized flanking residues to maximize discrimination from the adjacent Tyr171 site and the non-phosphorylated form.
• Immunization & Two-Round Purification: Rabbits were immunized with the KLH-conjugated phospho-peptide. Serum was subjected to two-round affinity purification: positive selection on the phospho-peptide column, followed by negative depletion against both the unmodified peptide and a phospho-Tyr171 peptide to ensure exclusive Thr172 specificity.
• Validation in Tomato Samples: The anti-PIP1;2(pT172) antibody was validated by Western Blot using tomato mutant samples (GGC1 knockout vs. wild-type), confirming specific detection of phosphorylated PIP1;2 with quantifiable signal differences between genotypes.

Research Outcomes and Impact

The custom anti-PIP1;2(pT172) antibody provided the critical experimental evidence enabling the research team to demonstrate that GGC1 negatively regulates photosynthetic efficiency and plant vigor by suppressing CPK28-mediated phosphorylation of PIP1;2 at Thr172. This discovery revealed a previously unknown G protein–mediated signaling cascade governing crop growth, with direct implications for breeding strategies to improve tomato yield through manipulation of the GGC1–CPK28–PIP1;2 pathway.

Figure 1. Functional divergence of G protein γ subunits in tomato. GGC1 suppresses CPK28-mediated phosphorylation of PIP1;2 at Thr172, negatively regulating plant vigor and photosynthesis.

Figure 2. Western Blot validation of PIP1;2 Thr172 phosphorylation using AtaGenix custom phospho-specific antibody. Quantitative detection in tomato GGC1 mutant vs. wild-type samples confirmed the regulatory relationship.

This case study is based on a published research collaboration. Results may vary depending on target species, modification site, and experimental conditions. All proprietary client information is subject to NDA. Reference: Cell Reports. DOI: see original publication.